In Brief This Week: RUCDR Infinite Biologics; Expression Analysis/Quintiles, Illumina; Thermo Fisher; Analytik Jena; Appistry; Acobiom; Genoway | GenomeWeb

NEW YORK (GenomeWeb) – RUCDR Infinite Biologics said this week it received CLIA certification. The unit of Rutgers' Human Genetics Institute of New Jersey also received a Clinical Laboratory Improvement Services license from New Jersey. RUCDR, which calls itself the world's largest university-based biorepository, said it plans to provide clinical-grade diagnostics for a range of diseases, and will use genetic and genomic technologies to develop tests for diagnosing and managing several types of cancers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.